GTCR taps $5.25bn Fund XII to build life science, tech-focused Corza Health

Chicago buyout house GTCR has used its $5.25bn Fund XII to launch a new life science and health technology-focused business, Corza Health, in partnership with healthcare industry veteran Gregory T Lucier.